{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T20:10:19Z","timestamp":1740341419041,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1007\/bf03189353","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T00:07:34Z","timestamp":1280880454000},"page":"287-294","source":"Crossref","is-referenced-by-count":2,"title":["Distribution of fenofibric acid in lipoprotein fractions of patients"],"prefix":"10.1007","volume":"23","author":[{"given":"M.","family":"Nobilis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kvetina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Anzenbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Vontor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Svoboda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Br\u00e1tov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Solichov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Zad\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bl\u00e1ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vlcek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03189353_CR1","first-page":"885","volume":"26","author":"R. Sornay","year":"1976","unstructured":"Sornay R., Gurrieri J., Tourne C., Renson F.J., Majoie B. and W\u00fclfert E. (1976): Antilipidemic Drugs. Part 1. Synthesis and structure-activity relationship of new alcoyl and benzoyl phenoxy carboxylic acids. Arzneim.-Forsch., 26, 885\u2013889.","journal-title":"Arzneim.-Forsch."},{"key":"BF03189353_CR2","first-page":"889","volume":"26","author":"J. Gurrieri","year":"1976","unstructured":"Gurrieri J., Le Lous F.J., Renson F.J., et al. (1976): Antilipidemic Drugs. Part 2. Experimental study of a new potent hypolipidemic drug, isopropyl \u2014 [4\u2032-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF 178). Arzneim.-Forsch, 26, 889\u2013894.","journal-title":"Arzneim.-Forsch"},{"key":"BF03189353_CR3","first-page":"901","volume":"26","author":"J. Rouffy","year":"1976","unstructured":"Rouffy J., Dreux C., Goussault Y., Dakkak R. and Renson F.J. (1976): Antilipidemic Drugs. Part 5. Evaluation of the hypolipidemic effect of LF-178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV). Arzneim.-Forsch., 26, 901\u2013906.","journal-title":"Arzneim.-Forsch."},{"key":"BF03189353_CR4","first-page":"906","volume":"26","author":"E. W\u00fclfert","year":"1976","unstructured":"W\u00fclfert E., Majoie B. and de Ceaurriz A. (1976): Antilipidemic Drugs. Part 6. LF-178 in man. A preliminary note on a multicenter investigation bearing on 393 subjects with pure or mixed forms of hyperlipidemia. Arzneim.-Forsch, 26, 906\u2013909.","journal-title":"Arzneim.-Forsch"},{"key":"BF03189353_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01061412","volume":"34","author":"S. Bertolini","year":"1988","unstructured":"Bertolini S., Elicio N., Daga A., et al. (1988): Effect of a single daily dose treatment of fenofibrate on plasma lipoproteins in hyperlipoproteinaemia IIb. Eur. J. Clin. Pharmacol, 34, 25\u201328.","journal-title":"Eur. J. Clin. Pharmacol"},{"issue":"Suppl. 5B","key":"BF03189353_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0002-9343(87)90867-9","volume":"83","author":"M.J. Chapman","year":"1987","unstructured":"Chapman M.J. (1987): Pharmacology of fenofibrate. Am. J. Med., 83 (Suppl. 5B), 21\u201325.","journal-title":"Am. J. Med."},{"key":"BF03189353_CR7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2165\/00003495-199040020-00007","volume":"40","author":"J.A. Balfour","year":"1990","unstructured":"Balfour J.A., McTavish D., Hell R.C. (1990): Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia. Drugs, 40, 260\u2013290.","journal-title":"Drugs"},{"key":"BF03189353_CR8","first-page":"896","volume":"26","author":"R.R. Brodie","year":"1976","unstructured":"Brodie R.R., Chasseaud L.F., Elsom F.F., Franklin E.R. and Taylor T. (1976): Antilipidemic Drugs. Part 4. The metabolic fate of the hypolipidemic agent isopropyl \u2014 [4\u2032-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF 178) in rats, dog and man. Arzneim.-Forsch., 26, 896\u2013901.","journal-title":"Arzneim.-Forsch."},{"key":"BF03189353_CR9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0021-9673(00)82222-0","volume":"123","author":"L.F. Elsom","year":"1976","unstructured":"Elsom L.F., Hawkins D.R. and Chasseaud L.F. (1976): Identification of a major metabolite of the new hypolipidaemic agent, isopropyl \u2014 [4\u2032-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (procetofene) in humans by GC-MS. J. Chromatogr., 123, 463\u2013467.","journal-title":"J. Chromatogr."},{"key":"BF03189353_CR10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0163-7258(85)90028-2","volume":"29","author":"M.N. Cayen","year":"1985","unstructured":"Cayen M.N. (1985): Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man. Pharmacol. Ther. 29, 157\u2013204","journal-title":"Pharmacol. Ther."},{"key":"BF03189353_CR11","unstructured":"Caldwell J., Strolin-Benedeti M., Weil A. (1986): Comparative metabolism of fenofibrate in rats and human volunteers. Br. J Clin. Pharmacol. 22, 219P"},{"key":"BF03189353_CR12","first-page":"167","volume":"59","author":"M. Strolin-Benedetti","year":"1986","unstructured":"Strolin-Benedetti M., Guichard J.P., Vidal R., Donath A (1986): Kinetics and metabolic fate of14C-fenofibrate in human plasma. Acta Pharmacol. Toxicol. 59, 167 (Abstract 456)","journal-title":"Acta Pharmacol. Toxicol"},{"key":"BF03189353_CR13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0090-9556(25)06933-8","volume":"16","author":"A. Weil","year":"1988","unstructured":"Weil A., Caldwell J., Strolin-Benedetti M. (1988): The metabolism and disposition of fenofibrate in rat, guinea pig and dog. Drug Metab. Dispos., 16, 302\u2013309","journal-title":"Drug Metab. Dispos."},{"key":"BF03189353_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0090-9556(25)07578-6","volume":"18","author":"A. Weil","year":"1990","unstructured":"Weil A., Caldwell J., Strolin-Benedetti M. (1990): The metabolism and disposition of fenofibrate in human volunteers. Drug. Metab. Disp., 18, 115\u2013120","journal-title":"Drug. Metab. Disp."},{"key":"BF03189353_CR15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0378-4347(00)81681-3","volume":"145","author":"J.P. Desager","year":"1978","unstructured":"Desager J.P. (1978): GLC determination of procetofenic acid in human plasma and urine. J. Chromatogr., 145, 160\u2013164.","journal-title":"J. Chromatogr."},{"key":"BF03189353_CR16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0378-4347(00)80227-3","volume":"224","author":"C. Luley","year":"1981","unstructured":"Luley C., Kegel H. and Jakobs C. (1981): Improved method for the determination of procetofenic acid in human plasma by GLC. J. Chromatogr., 224, 500\u2013502","journal-title":"J. Chromatogr."},{"key":"BF03189353_CR17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-4347(00)80375-8","volume":"227","author":"M.C. Caturla","year":"1982","unstructured":"Caturla M.C. and Albaigs J. (1982): Rapid determination of procetofenic acid in plasma by HPLC. J. Chromatogr., 227, 219\u2013222","journal-title":"J. Chromatogr."},{"key":"BF03189353_CR18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0378-4347(00)83489-1","volume":"383","author":"A. Cotta-Ramusino","year":"1986","unstructured":"Cotta-Ramusino A. and Carozzi A. (1986): Simple and rapid method for determining procetofenic acid, an active metabolite of procetofenon, in biological fluids by solidphase extraction and HPLC. J. Chromatogr., 383, 419\u2013424","journal-title":"J. Chromatogr."},{"key":"BF03189353_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/chir.530010304","volume":"1","author":"A. Weil","year":"1989","unstructured":"Weil A., Caldwell J., Guichard J.P., Picot G. (1989): Species differences in the chirality of the carbonyl reduction of14C-fenofibrate in laboratory animals and humans. Chirality, 1, 197\u2013201","journal-title":"Chirality"},{"issue":"2","key":"BF03189353_CR20","first-page":"202","volume":"23","author":"J. Kvetina","year":"1998","unstructured":"Kvetina J., Nobilis M., Svoboda Z., Anzenbacher P., Svoboda D., Zad\u00e1k Z., Bl\u00e1ha V., Havel E. (1998) [Title page 202]: Eur. J. Drug Metab. Pharmacokin., 23 (2): 202\u2013208","journal-title":"Eur. J. Drug Metab. Pharmacokin."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03189353\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T19:30:09Z","timestamp":1740339009000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03189353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["BF03189353"],"URL":"https:\/\/doi.org\/10.1007\/bf03189353","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}